| ACPA | anti-citrullinated peptide/protein antibodies |
| ACR | American College of Rheumatology |
| ADA | anti-drug antibodies |
| AIA | adjuvant-induced arthritis |
| AIF | apoptosis-inducing factor |
| AKBA | acetyl keto boswellic acid |
| AKT | AKT serine/threonine kinase |
| AMPK | 5′-AMP-activated protein kinase catalytic subunit alpha-1 |
| AP-1 | adaptor protein 1 |
| APC | antigen-presenting cell |
| ARE | antioxidative response element |
| BAX | apoptosis regulator BAX |
| BCL-2 | apoptosis regulator Bcl-2 |
| Breg | B regulatory cells |
| CA | curculigoside A |
| CAT | catalase |
| CBD | cannabidiol |
| CCL-1 | monocyte chemoattractant protein-1 |
| CCR6 | chemokine receptor 6 |
| CDAI | Clinical Disease Activity Index |
| CIA | collagen-induced arthritis |
| COX | cyclooxygenase |
| CRP | C-reactive protein |
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
| CYP | cytochrome P450 |
| DAS | Disease Activity Score |
| DMARDs | disease-modifying antirheumatic drugs |
| EGCG | epigallocatechin gallate |
| EGFR | epidermal growth factor receptor |
| ERK | extracellular signal-regulated kinase |
| ESR | erythrocyte sedimentation rate |
| EULAR | European League Against Rheumatism |
| FGFR | fibroblast growth factor receptor 1 |
| FLS | fibroblast-like synoviocytes |
| GCQG | glucosamine-chondroitin-quercetin glucoside |
| GPX | glutathione peroxidase |
| GSH | glutathione |
| GWAS | genome-wide association studies |
| HAQ-DI | Health Assessment Questionnaire Disability Index |
| HLA | human leukocyte antigen |
| HO-1 | heme oxygenase-1 |
| HOMA-IR | Homeostatic Model Assessment of Insulin Resistance |
| ICAM-1 | intercellular adhesion molecule 1 |
| IL | interleukin |
| IL-23R | interleukin-23 receptor |
| INF-γ | interferon-γ |
| iNOS | inducible nitric oxide synthase |
| IRF5 | interferon regulatory factor 5 |
| IκBα | NF-kappa-B inhibitor alpha |
| JAK | Janus kinase |
| LPO | lipid peroxidase |
| LPS | lipopolysaccharide |
| MAPK | mitogen-activated protein kinase |
| MCL-1 | myeloid cell leukemia 1 |
| MDA | malondialdehyde |
| M-EC | membrane-camouflaged nanoparticles |
| MEK1 | dual specificity mitogen-activated protein kinase kinase 1 |
| MMP | matrix metalloproteinase |
| mPGES-1 | microsomal prostaglandin E2 synthase-1 |
| MPO | myeloperoxidase |
| MRQ | Maharasnadhi quathar |
| MTX | methotrexate |
| NFATc1 | nuclear factor of activated T cells 1 |
| NF-κB | nuclear factor kappa B |
| NO | nitric oxide |
| NOEL | no observed effect level |
| NPRS | Numeric Pain Rating Scale |
| NRF-2 | nuclear factor erythroid 2-related factor 2 |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| OA | osteoarthritis |
| PADI4 | protein-arginine deiminase type-4 |
| PARP-1 | poly ADPribose polymerase |
| PBS | phosphate buffered saline |
| PGE-2 | prostaglandin E2 |
| PI3K | phosphatidylinositol 4,5-bisphosphate 3-kinase |
| PKC | protein kinase C |
| PROs | patient-reported outcomes |
| PTPN22 | phosphatase non-receptor type 22 |
| RA | rheumatoid arthritis |
| RANKL | receptor activator for nuclear factor κB ligand |
| RBA | roburic acid |
| RF | rheumatoid factor |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| SE | shared epitope |
| SIRT1 | sirtuin 1 |
| SJC | swollen joint count |
| SOD | superoxide dismutase |
| STAT | signal transducer and activator of transcription |
| TBARS | thiobarbituric acid reacting substances |
| TGF-β | transforming growth factor β |
| THC | tetrahydrocannabinol |
| TJC | tender joint count |
| TNF-R1 | tumor necrosis factor receptor 1 |
| TNF-α | tumor necrosis factor-alpha |
| TRAF1/6 | TNF receptor-associated factor 1/6 |
| Tregs | regulatory T cells |
| UT | Uncaria tomentosa |
| VAS | Visual Analog Scale |
| VCAM-1 | vascular cell adhesion protein 1 |
| VEGF | vascular endothelial growth factor |
| VEGFR | vascular endothelial growth factor receptor |
| WC | Weldehi choornaya |
| WOMAC | Western Ontario and McMaster Universities Osteoarthritis Index |